Note to our followers: Our nearly 13-year run of daily publication of new content on came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Tags: migraine


Doctor’s $620,000 conflict of interest not disclosed in Inquirer story on new migraine drugs


Reuters numbs with numbers on experimental migraine drug


Philadelphia Inquirer story skirts discussion of evidence for experimental migraine drug


STAT’s look at migraine drugs in development skimmed over key research details


Bold claims for migraine treatment are based on opinions and anecdote in this story


Nerve Treatment Via Nose Shows Promise Against Migraines

1 1/23/2013

FDA Approves 1st Skin Patch to Combat Migraines


Preventive medicines can help migraine sufferers


Experts issue new guidelines for preventing migraines with drugs


Surgery for migraines: Help or hokum?